Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
作者:
主题词
成年人(Adult);老年人(Aged);血管生成抑制剂(Angiogenesis Inhibitors);抗肿瘤药(Antineoplastic Agents);伪迹(Artifacts);癌, 肾细胞(Carcinoma, Renal Cell);临床试验(主题)(Clinical Trials as Topic);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);吲哚类(Indoles);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);吡咯类(Pyrroles);结果可重复性(Reproducibility of Results);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.4143/crt.2014.289
PMID
25761478
发布时间
2018-12-02
- 浏览41
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文